Are you a clinician with access to oncology patients?
Partner with us in a cutting-edge pilot project to analyze somatic mutations in key oncogenes — powered by state-of-the-art sequencing from Novogene and advanced mutation analysis from WGSearcher.

Section 1: About the Project
Precision Oncology Starts Here
We are launching a pilot study in collaboration with Novogene, one of the world’s leading DNA sequencing providers. This project aims to streamline the workflow from patient sample to actionable genetic insight.
We are inviting a select group of clinicians to participate. If you have access to real patient samples and are interested in exploring the clinical relevance of somatic mutations in oncogenes, this is your opportunity to be part of an innovative research initiative.
Section 2: How It Works
Step-by-Step Workflow
- Patient Selection
You select patients (up to 10) who may benefit from somatic mutation analysis. - Sample Submission
Samples are sent to Novogene, who will perform high-quality sequencing. - Data Transfer
Novogene sends the resulting .bam files securely to you within 10 working days. - Advanced Analysis
WGSearcher performs in-depth analysis to identify somatic mutations in clinically relevant oncogenes. - Results Delivery
You will receive a detailed mutation report + the raw sequencing data.

Section 3: What You Get
- Mutation report tailored to each patient
- Access to raw .bam files for further research or archiving
- Insights into oncogene-driven mutations that may inform treatment decisions
- Early access to our analytical platform, including future tools and updates
- Priority support during the pilot
Section 4: Eligibility
- Licensed clinicians working in oncology, pathology, or related specialties
- Access to patient samples with proper ethical and legal approval
- Both you and your patients need to be in a judicial area where we can provide our services
- Willingness to provide feedback on report clarity and usefulness
Section 5: About WGSearcher & Novogene
WGSearcher is a precision genomics tool that identifies somatic mutations in cancer-linked genes from DNA sequencing files.
Novogene is a global leader in next-generation sequencing, delivering high-throughput and high-quality data for clinical and research applications.
Interested in Participating?
We’re currently enrolling 10 patients for the pilot.
Join us and help shape the future of clinical cancer genomics.
email us at: pilot@wgsearcher.com